J7518 HCPCS code: Mycophenolic acid, oral, 180 mg
J7518 is the HCPCS Level II code for mycophenolic acid, oral, 180 mg. In 2024 Medicare paid an average of $0.35 per service for J7518 across 38,508,277 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 720 per day on DME suppliers. Medicare volume fell 5% from 2022 to 2024 (40,377,476 to 38,508,277 services). In 2024, 8,540 suppliers billed Medicare for J7518 (purchases), serving 31,385 beneficiaries; California, Texas, Florida accounted for 24% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2005-01-01 |
| Last action effective | 2005-01-01 |
Who bills J7518 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 8,540 |
| Referring clinicians | 8,179 |
| Medicare beneficiaries | 31,385 |
| States with claims | 52 |
| Share of services in top 3 states (California, Texas, Florida) | 24% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 8,250 | 31,649 |
| 2023 | 8,356 | 31,571 |
| 2024 | 8,540 | 31,385 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7518, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 40,377,476 | 31,649 | $1.24 | $0.94 |
| 2023 | 39,126,305 | 31,571 | $0.73 | $0.54 |
| 2024 | 38,508,277 | 31,385 | $0.48 | $0.35 |
States with the most J7518 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 3,759,017 | $0.35 |
| Texas | 2,924,089 | $0.35 |
| Florida | 2,503,285 | $0.36 |
| Wisconsin | 2,063,254 | $0.36 |
| Illinois | 2,058,629 | $0.36 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 720 | CMS Policy |
| outpatient hospital claims | 12 | Clinical: Society Comment |
What changed for J7518
- 2005-01-01: J7518 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7518?
J7518 is the HCPCS Level II code for mycophenolic acid, oral, 180 mg. Short descriptor: "Mycophenolic acid".
How much does Medicare pay for J7518?
In 2024, the average Medicare payment was $0.35 per service (average allowed $0.48).
Does Medicare cover J7518?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J7518 can be billed per day?
720 on DME suppliers; 12 on outpatient hospital claims (NCCI medically unlikely edits).
Related J75 codes
- J7500 — Azathioprine, oral, 50 mg
- J7501 — Azathioprine, parenteral, 100 mg
- J7502 — Cyclosporine, oral, 100 mg
- J7503 — Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504 — Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505 — Muromonab-cd3, parenteral, 5 mg
- J7506 — Prednisone, oral, per 5 mg
- J7507 — Tacrolimus, immediate release, oral, 1 mg
- J7508 — Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509 — Methylprednisolone oral, per 4 mg
- J7510 — Prednisolone oral, per 5 mg
- J7511 — Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7518
- Watch J7518 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7518
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.